Orchestra BioMed Holdings, Inc. (OBIO) Operating margin 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-154.7%FY2025 · since FY2022: -924.3% → -154.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -154.7% | +2282.8 pp |
| FY2024 | -2437.5% | -571.3 pp |
| FY2023 | -1866.2% | -941.8 pp |
| FY2022 | -924.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice